What is the treatment for a Vitamin B12 level of 157?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A Vitamin B12 level of 157 pg/mL is considered low and requires immediate supplementation with hydroxocobalamin 1 mg intramuscularly three times a week for 2 weeks, as per NICE recommendations 1. Given the low Vitamin B12 level, it is crucial to initiate treatment promptly to prevent further complications.

  • The treatment approach should follow the guidelines outlined by NICE, which recommend administering hydroxocobalamin 1 mg intramuscularly three times a week for 2 weeks for individuals with no neurological involvement 1.
  • After the initial treatment phase, maintenance treatment with 1 mg intramuscularly every 2–3 months lifelong is recommended to ensure that the Vitamin B12 levels remain within the normal range 1.
  • It is essential to note that folic acid should not be given first, as it may mask underlying Vitamin B12 deficiency and precipitate subacute combined degeneration of the spinal cord 1.
  • If there is possible neurological involvement, such as unexplained sensory and/or motor and gait symptoms, urgent specialist advice from a neurologist and haematologist should be sought 1.
  • The underlying cause of the deficiency should be identified and addressed to prevent future deficiencies.

From the Research

Treatment for Vitamin B12 Level of 157

The treatment for a Vitamin B12 level of 157 is primarily focused on addressing the underlying cause of the deficiency and replenishing Vitamin B12 stores.

  • Oral administration of high-dose Vitamin B12 (1 to 2 mg daily) is as effective as intramuscular administration for correcting anemia and neurologic symptoms 2.
  • Intramuscular therapy leads to more rapid improvement and should be considered in patients with severe deficiency or severe neurologic symptoms 2.
  • A study on oral Vitamin B12 supplementation in pernicious anemia found that 88.5% of patients were no longer deficient in Vitamin B12 after 1 month of oral cyanocobalamin supplementation at a dosage of 1000 μg/d 3.

Diagnosis and Assessment

  • Initial laboratory assessment should include a complete blood count and serum Vitamin B12 level 2.
  • Measurement of serum methylmalonic acid should be used to confirm deficiency in asymptomatic high-risk patients with low-normal levels of Vitamin B12 2.
  • Diagnostic biomarkers for Vitamin B12 status include decreased levels of circulating total Vitamin B12 and transcobalamin-bound Vitamin B12, and abnormally increased levels of homocysteine and methylmalonic acid 4.

Management and Prevention

  • Management depends on Vitamin B12 supplementation, either via high-dose oral routes or via parenteral administration 4.
  • Patients older than 50 years and vegans or strict vegetarians should consume foods fortified with Vitamin B12 or take Vitamin B12 supplements to improve absorption rates 2.
  • Patients who have had bariatric surgery should receive 1 mg of oral Vitamin B12 per day indefinitely 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vitamin B12 Deficiency: Recognition and Management.

American family physician, 2017

Research

Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study.

The American journal of clinical nutrition, 2024

Research

Vitamin B12 deficiency.

Nature reviews. Disease primers, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.